gptkbp:instanceOf
|
gptkb:chemical_compound
imidazoline derivative
|
gptkbp:ATCCode
|
S01GA02
|
gptkbp:brand
|
gptkb:Visine
Murine
Opti-Clear
|
gptkbp:CASNumber
|
84-22-0
|
gptkbp:chemicalFormula
|
C13H16N2
|
gptkbp:contraindication
|
narrow-angle glaucoma
|
gptkbp:discoveredIn
|
1950s
|
https://www.w3.org/2000/01/rdf-schema#label
|
tetrahydrozoline
|
gptkbp:IUPACName
|
2-(1,2,3,4-tetrahydro-1-naphthyl)imidazoline
|
gptkbp:KEGGID
|
D01441
|
gptkbp:legalStatus
|
OTC (over-the-counter)
|
gptkbp:mechanismOfAction
|
alpha-adrenergic receptor agonist
|
gptkbp:meltingPoint
|
97–98 °C
|
gptkbp:molecularWeight
|
200.28 g/mol
|
gptkbp:pregnancyCategory
|
C (US)
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL1201292
5457
DB06764
|
gptkbp:riskFactor
|
toxicity if ingested
|
gptkbp:routeOfAdministration
|
topical
|
gptkbp:sideEffect
|
blurred vision
allergic reaction
eye irritation
rebound hyperemia
|
gptkbp:solubility
|
soluble in water
|
gptkbp:UNII
|
K50L3C5399
|
gptkbp:usedAs
|
vasoconstrictor
|
gptkbp:usedFor
|
relief of nasal congestion
relief of eye redness
|
gptkbp:usedIn
|
nasal sprays
eye drops
|
gptkbp:bfsParent
|
gptkb:Visine
|
gptkbp:bfsLayer
|
7
|